Related Experiment Video
Updated: Aug 6, 2026

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
[Macroangiopathy in type II diabetes. The Raval South study]
T Mur Martí1, J Franch Nadal, J Morato Griera
1Area Básica de Salud Raval Sud, Barcelona.
Objective:
To study the prevalence of clinical forms of diabetic macroangiopathy (DM) and its risk factors.
Design:
A descriptive crossover study.
Setting:
An elderly and socio-economically very depressed population in Raval Sud Health District (HD), Barcelona.
Patients And Other Participants:
Random sampling of type II diabetes patients (n = 387) registered in the HD (6.6% prevalence).
Measurements And Main Results:
Each patient was examined for the presence of diagnostic criteria of peripheric, cerebral or coronary vasculopathy (VP); as well as for the possible risk factors (age, gender, years of the DM's evolution, tobacco, hypertension, obesity, glycosilated haemoglobin and dyslipemia). Prevalences obtained were: peripheric VP = 24.5%, cerebral VP = 9.5%, coronary VP = 18.1%. 30.5% of the diabetics had some form of macroangiopathy. The main risk factors for all the clinical forms (p < 0.001) were age and the length of evolution of DM, tobacco mainly for peripheric VP (p < 0.001), systolic Hypertension for cerebral VP (p = 0.03) and Hypertriglyceridaemia for peripheric VP (p < 0.01).
Conclusions:
Macroangiopathy affects a high percentage (30.5%) of type 2 diabetics. The principal risk factors are those associated with tobacco, hypertension and hypertriglyceridaemia, all of which we can affect and control.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes III: Clinical Manifestations
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Retinopathy

